Alfaifi, A.; Refai, M.Y.; Alsaadi, M.; Bahashwan, S.; Malhan, H.; Al-Kahiry, W.; Dammag, E.; Ageel, A.; Mahzary, A.; Albiheyri, R.;
et al. Metabolomics: A New Era in the Diagnosis or Prognosis of B-Cell Non-Hodgkin’s Lymphoma. Diagnostics 2023, 13, 861.
https://doi.org/10.3390/diagnostics13050861
AMA Style
Alfaifi A, Refai MY, Alsaadi M, Bahashwan S, Malhan H, Al-Kahiry W, Dammag E, Ageel A, Mahzary A, Albiheyri R,
et al. Metabolomics: A New Era in the Diagnosis or Prognosis of B-Cell Non-Hodgkin’s Lymphoma. Diagnostics. 2023; 13(5):861.
https://doi.org/10.3390/diagnostics13050861
Chicago/Turabian Style
Alfaifi, Abdullah, Mohammed Y. Refai, Mohammed Alsaadi, Salem Bahashwan, Hafiz Malhan, Waiel Al-Kahiry, Enas Dammag, Ageel Ageel, Amjed Mahzary, Raed Albiheyri,
and et al. 2023. "Metabolomics: A New Era in the Diagnosis or Prognosis of B-Cell Non-Hodgkin’s Lymphoma" Diagnostics 13, no. 5: 861.
https://doi.org/10.3390/diagnostics13050861
APA Style
Alfaifi, A., Refai, M. Y., Alsaadi, M., Bahashwan, S., Malhan, H., Al-Kahiry, W., Dammag, E., Ageel, A., Mahzary, A., Albiheyri, R., Almehdar, H., & Qadri, I.
(2023). Metabolomics: A New Era in the Diagnosis or Prognosis of B-Cell Non-Hodgkin’s Lymphoma. Diagnostics, 13(5), 861.
https://doi.org/10.3390/diagnostics13050861
